These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of therapeutic siRNAs for pachyonychia congenita. Smith FJ; Hickerson RP; Sayers JM; Reeves RE; Contag CH; Leake D; Kaspar RL; McLean WH J Invest Dermatol; 2008 Jan; 128(1):50-8. PubMed ID: 17762855 [TBL] [Abstract][Full Text] [Related]
5. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita. Liao H; Sayers JM; Wilson NJ; Irvine AD; Mellerio JE; Baselga E; Bayliss SJ; Uliana V; Fimiani M; Lane EB; McLean WH; Leachman SA; Smith FJ J Dermatol Sci; 2007 Dec; 48(3):199-205. PubMed ID: 17719747 [TBL] [Abstract][Full Text] [Related]
6. SiRNA-mediated selective inhibition of mutant keratin mRNAs responsible for the skin disorder pachyonychia congenita. Hickerson RP; Smith FJ; McLean WH; Landthaler M; Leube RE; Kaspar RL Ann N Y Acad Sci; 2006 Oct; 1082():56-61. PubMed ID: 17145926 [TBL] [Abstract][Full Text] [Related]
7. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita. Wu TT; Eldirany SA; Bunick CG; Teng JMC J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063 [TBL] [Abstract][Full Text] [Related]
8. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. Terrinoni A; Smith FJ; Didona B; Canzona F; Paradisi M; Huber M; Hohl D; David A; Verloes A; Leigh IM; Munro CS; Melino G; McLean WH J Invest Dermatol; 2001 Dec; 117(6):1391-6. PubMed ID: 11886499 [TBL] [Abstract][Full Text] [Related]
9. Pachyonychia congenita: a case report. Kohli N Cutis; 2009 Nov; 84(5):269-71. PubMed ID: 20099620 [TBL] [Abstract][Full Text] [Related]
10. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation. Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339 [TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling, keratin 6 induction, and sebaceous gland morphogenesis: implications for pachyonychia congenita and related conditions. Gu LH; Coulombe PA Am J Pathol; 2008 Sep; 173(3):752-61. PubMed ID: 18688029 [TBL] [Abstract][Full Text] [Related]
12. A novel missense mutation L468Q of keratin 6a in pachyonychia congenita type 1. Zhou HL; Yang S; Gao M; Zhao XY; Zhu YG; Li W; Ren YQ; Liang YH; Du WH; Zhang XJ J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):351-5. PubMed ID: 17309457 [TBL] [Abstract][Full Text] [Related]
13. [The 521 T--> C mutation in the keratin 6A gene in a pedigree with pachyonychia congenita type I]. Yang L; Li M; Lai M; Ni J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):66-8. PubMed ID: 20140871 [TBL] [Abstract][Full Text] [Related]
15. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Mo H; Elson CE Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351 [TBL] [Abstract][Full Text] [Related]
16. Phenotype and genotype features of Vietnamese children with pachyonychia congenita. Chu HT; Dinh Duong TA; Le DH; Le TV; Nguyen BB; Dang CV; Vu QV Pediatr Neonatol; 2023 Jul; 64(4):405-410. PubMed ID: 36658016 [TBL] [Abstract][Full Text] [Related]